BioSpace News Archive

Drug Development

Day After Intercept’s Setback, Akero’s EFX Shows Promise in NASH Trial

Of the 40 patients who responded who had end-of-treatment biopsies, 48% showed at least a one-stage improvement in fibrosis without worsening of NAFLD activity score and 28% demonstrated at least a two-stage improvement in fibrosis.

July 1, 2020
·
3 min read
·
Mark Terry
BioMidwest

Research Roundup: Multiple Molecules that Can Shut Down COVID-19 and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

July 1, 2020
·
6 min read
·
Mark Terry
FDA

FDA Gives Pfizer and Merck KGaA’s Bavencio a Thumbs-Up for Urothelial Cancer

Bavencio is an anti-PD-L1 checkpoint inhibitor co-developed by Merck KGaA, Darmstadt, German and Pfizer via EMD Serono, a business unit of the two companies.

July 1, 2020
·
3 min read
·
Mark Terry
A New H1N1 Strain From China May Trigger Another Pandemic

Another pandemic may be building in China. This time, it’s a new strain of the H1N1 swine flu and it’s already jumped to humans.

July 1, 2020
·
4 min read
·
Gail Dutton
Biotech Bay

Bolt Biotherapeutics Pushes Forward with Initiatives Following $93.5 Million Series C

Clinical-stage biotechnology company Bolt Biotherapeutics announced today that it has completed a $93.5 million Series C round of financing, led by Sofinnova Investments.

July 1, 2020
·
3 min read
·
Krystle Vermes
Drug Development

Pfizer and BioNTech’s COVID-19 Vaccine Shows Early Positive Data

Pfizer and BioNTech indicate that this data, along with preclinical data and additional data being generated, will be leveraged to choose a dose level and pick the best vaccine candidate out of the several being evaluated.

July 1, 2020
·
4 min read
·
Mark Terry
Policy

Justice Department Charges Glenmark Pharma with Price Fixing for Generic Drugs

The U.S. Justice Department charged Glenmark Pharmaceuticals, headquartered in India, with conspiring with other generic drug companies to increase and hold prices for the cholesterol drug pravastatin between May 2013 and December 2015.

July 1, 2020
·
3 min read
·
Mark Terry
Business

Strategies to Help You Get the Most Value from Regulatory Affairs Professionals

Meet with regulatory affairs professionals early and often. That’s the message from Neelu Gibson, VP, regulatory affairs, at BD, speaking at Biocom’s June virtual meeting, “Regulatory Affairs…Engagement Do’s & Don’ts.”

July 1, 2020
·
5 min read
·
Gail Dutton
Softbox launches ECO packaging solution for the pharma cold chain industry

Softbox, a leading global innovator and provider of temperature control packaging solutions for the pharmaceutical, life science and cold chain logistic industries, today announced the launch of Tempcell™ ECO, a new curbside-recyclable temperature control parcel shipper.

July 1, 2020
·
2 min read
Business

CONMED Corporation to Announce Second Quarter 2020 Financial Results on July 29, 2020

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter of 2020 after the market close on Wednesday, July 29, 2020.

July 1, 2020
·
2 min read